Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "pharmaceutical company"
Home
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?
A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World Health Organization is considering...
05/27/2026, 22:28 ET
Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics
Daewoong Pharmaceutical is accelerating its research and development into anti-aging therapeutics. The company announced on the 21st that it has...
05/26/2026, 04:18 ET
When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults
When recurring abdominal pain and diarrhea strike, most people first assume they are dealing with a standard bout of...
05/20/2026, 21:00 ET
Rejuran Cosmetics Sales Surge 51%: PharmaResearch Finds New Growth Engine
PharmaResearch is successfully diversifying its business model, transitioning from a medical device-centric structure...
05/16/2026, 22:56 ET
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years
Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying...
05/14/2026, 05:07 ET
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection
Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection...
05/12/2026, 05:17 ET
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge
More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
04/24/2026, 05:13 ET
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions
Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
04/09/2026, 01:13 ET
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?
A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...
04/04/2026, 08:51 ET
“We Can’t Afford Dad's Medicine”: The Heartbreaking Reality of Late-Stage Cancer Costs
“Should we sell the house? Dad’s medication is just too expensive.” This is the agonizing question keeping a mother in...
03/30/2026, 02:17 ET
Previous
4
5
6
7
8
Next